A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.

The NHS says that the “net” they’re talking about shows up as “red or blue coloured blotches on white skin, and dark or brownish coloured blotches on black and brown skin” It ... puts chunks of ...